Publication: Benefits of early application of pelvic circumferential compression device to reduce bleeding in pelvic fractures
0
0
Issued Date
2022
Resource Type
Language
eng
File Type
application/pdf
ISSN
14712474
Rights Holder(s)
Scopus
Bibliographic Citation
19th International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology, ECTI-CON 2022. Vol , No. (2022), p.-
Suggested Citation
Rungsinaporn V., Akkarawanit P., Kongmalai P. Benefits of early application of pelvic circumferential compression device to reduce bleeding in pelvic fractures. 19th International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology, ECTI-CON 2022. Vol , No. (2022), p.-. doi:10.1186/s12891-022-05166-3 Retrieved from: https://hdl.handle.net/20.500.14740/10345
Author(s)
Abstract
Background: To study of efficacy of early pelvic circumferential compression device using in patients with suspected pelvic trauma, compared with conventional stepwise approach. Methods: Traumatic injury and at least one of the following criteria are required for inclusion: loss of consciousness or a Glasgow coma score (GCS) of less than 13; systolic blood pressure less than 90 mmHg; falling from more than 6 m; injury to several important organs; and a positive pelvic compression test. Patients who satisfied the inclusion criteria for the experimental group were given an early application of a commercial pelvic sling beginning in July 2019. The control group consisted of cases who got the device after clinical or radiological confirmation of a pelvic fracture in the previous year. Gender, age, mechanism of injury, GCS, hospital stay, amount of packed red blood cell transfusion, hematocrit in emergency room, and hematocrit 24 h after application of pelvic binder were all assessed and compared. Results: The study had a total of 30 participants, with 15 in each group. The number of packed red blood cell transfusions in the early pelvic binder group (0.80 ± 1.42) is considerably lower than in the control group (2.4 ± 2.32) (P = 0.008), although the hematocrit change is not statistically different between the groups (2.1 VS 0.7) (P = 0.191). The time it took to install a pelvic binder was considerably shorter in the early pelvic binder group (16.40 ± 5.45) than in the control group (40.40 ± 13.64) (P = 0.001). There were no problems associated to soft tissue and skin necrosis in either group of patients. Conclusions: The use of the PCCD for 24 h prior to clinical and radiographic confirmation has significantly reduced the rate of packed red blood cell transfusion in any pelvic fracture patient without device-related complications. Trial registration: The study was entered into the Thai Clinical Trials Registry (TCTR20210809007). © 2022, The Author(s).